![]() | Only 14 pages are availabe for public view |
Abstract Cutaneous warts are the result of infection of the epidermis with human papilloma virus (HPV). Different HPV types are responsible for particular clinical varieties such as common, plane, plantar, mosaic, ano-genital and oral warts. Warts are refractory to treatment. Many lines of treatment are available but none is eradicative and most of them have limited efficacy and show relapse. Numerous therapeutic modalities are available for warts with variable success rates. These include topical therapies such as salicylic acid, tretinoin, podophyllotoxin, trichloroacetic acid, formaldehyde, 5-fluorouracil, immunomodulating agents, photodynamic therapy, systemic retinoids, surgical/cytotoxic modalities such as cryotherapy, laser ablation, intralesional bleomycin, electrocautery, and surgical excision. Warts become recalcitrant after conventional treatment for several months such as, 12 week of salicylic acid application, 4 or more cycles of cryotherapy or electrocautery and/or other physical treatment modalities. Vitamin A is a fat solubale vitamin, has several natural and synthetic forms. Vitamin A plays an important role in epithelial cell differentiation, keratin expression and immunity. Retinoids are synthetic forms of vitamin A, which showed great succeful rate for the treatment of recalcitrant warts, by their topical or systemic forms. Vitamin A is transported to the tissues in the form of retinol bound to a protein produced by the liver called retinol binding protein (RBP) which present in circulation in equimolar concentrations with retinol, in addition to refrigeration and laboratory facilities for RBP are cheaper than those of retinol, also more accurate results may be obtained from measuring RBP than measuring retinol as an indicator of vitamin A status in the body. So our aim in this study was to evaluate the serum RBP level as an indicator of vitamin A status in resistant cutaneous warts patients to assess its correlation to the disease pathogenesis. This case control study was conducted on 60 subjects, who were divided into two groups, group (1) included 30 cases of recalcitrant cutaneous warts after conventional treatment for several months as 12 week salicylic acid application, 4 or more cycles of cryotherapy or electrocautery and/or other physical treatment modalities, group (2) included 30 apparently healthy subjects of matched age and sex, who were chosen as a control. Patients were selected from the dermatological outpatient clinic, Faculty of Medicine, Menoufia University Hospital, during the period from July 2019 to November 2019. All the studied groups were subjected to complete history taking. Both general and dermatological examination were performed. Venous blood sample (3ml) was collected from every subject under complete aseptic condition, left to coagulate at room temperature, then centrifuged at a speed of 4000 r.p.m for 10 minutes. The serum obtained was stored at -20 c until analysis of serum RBP by an enzyme linked immunosorbent assay (ELISA) technique. |